Australian Pharma Stock News

Founder-led stocks can offer something many investors look for, especially when global data feels mixed on growth, inflation, and policy direction. With services sectors holding up in several regions, inflation showing pockets of relief, and energy and geopolitical risks still in focus, commitment at the top of a company can matter even more. The Top Founder-Led Companies screener focuses on leaders with meaningful skin in the game and strong capital efficiency, so you are not just backing a...

AI is no longer just a big tech story. While global data points show mixed growth, cooling inflation in some regions and a steady recovery in services and manufacturing, smaller AI-focused companies are quietly building tools in machine learning, automation, and data intelligence that aim to solve very specific problems. That is where the AI Small Caps screener comes in. It helps you filter for early-stage opportunities that might otherwise be buried under the headlines about mega caps. In...

Elevra Lithium has completed the groundbreaking of its North American Lithium Expansion project, following a May 2026 capital raise that fully funded Stage 1 and allowed equipment orders to support its planned development timeline. By targeting a 15–20% uplift in spodumene concentrate capacity and lower unit operating costs, the expansion underlines Elevra Lithium’s push to supply more traceable lithium to electric vehicle and energy storage customers. Next, we’ll examine how fully funded...

Gold mining stocks are back in focus after a key shift in the macro backdrop. Softer U.S. jobs data, reduced expectations for further Federal Reserve rate hikes and renewed central bank demand for bullion have all supported gold prices, giving fresh attention to companies that pull the metal out of the ground. For investors, that combination can change how risk and reward stack up across gold mining stocks screened for financial strength and specific country exposure. This article looks at 3...

In a world where inflation signals, interest rate expectations and growth data keep shifting, many investors are looking for income that feels more reliable than the latest macro headline. That is where Dividend Powerhouses with yields above 5% and well covered, growing payouts can help. This screener focuses on companies that have kept dividends both stable and on an upward path, which can be appealing when bond yields, labor data and central bank messages keep moving around. In this...

Penny stocks often sound like pure speculation, but the Financially Fit Penny Stocks screener takes a very different approach. With inflation, interest rate decisions and mixed economic data moving markets, many investors are looking for smaller companies with healthier balance sheets instead of chasing every headline. This screener focuses on penny stocks trading below $5 that also show solid financial health, which can help you focus on businesses with a lower risk profile than many early...

In recent weeks, Evolution Mining has been in focus as gold prices rebounded on a softer US dollar and easing interest-rate expectations, lifting investor attention on the company’s gold and copper exposure. At the same time, investors are increasingly weighing Evolution’s operational quality, cost control and balance sheet strength rather than relying solely on broad gold sector momentum. We’ll now examine how this renewed focus on operational quality amid improving gold prices may...

As the Australian market opens the new financial year flat, with the ASX hovering around 8,780 points, global markets are showing mixed signals amid ongoing geopolitical tensions and tech-driven rallies. In such a landscape, identifying promising investment opportunities requires a keen eye for stocks that balance affordability with potential for growth. Penny stocks, often representing smaller or newer companies, continue to capture investor interest due to their unique blend of...

In the past few days, Cochlear Limited cut its FY26 underlying net profit guidance to A$290 million–A$330 million, citing weaker implant demand in developed markets, Middle East delivery and receivables risk, margin pressure, and higher restructuring costs. This guidance downgrade highlights how operational challenges in key geographies and rising costs can alter expectations for a business often viewed as a core ASX healthcare exposure. We’ll now examine how Cochlear’s reduced FY26 profit...

Telix Pharmaceuticals (ASX:TLX) is back in focus after a Type B meeting with the U.S. Food and Drug Administration confirmed that safety data from its ProstACT Global Phase 3 trial supports moving TLX591-Tx into Part 2. See our latest analysis for Telix Pharmaceuticals. Alongside the FDA update, Telix Pharmaceuticals has drawn fresh attention after a strong 30-day share price return of 36.03% and year to date share price return of 51.23%. However, the 1-year total shareholder return declined...

With inflation signals mixed and central banks keeping options open on interest rates, many investors are looking for assets tied to real world energy demand rather than just policy swings. Nuclear energy stocks sit squarely in that camp, linking company fortunes to long term power needs, supply chains and geopolitical decisions around fuel security. The Nuclear Energy Stocks screener is designed to help you focus on listed businesses across uranium production, enrichment and reactor...

The recent move in nickel and cobalt prices, together with investor caution around funding large battery metals projects, has put Sunrise Energy Metals (ASX:SRL) back in focus for sector risk and valuation. See our latest analysis for Sunrise Energy Metals. Despite recent sector-wide pressure that saw Sunrise Energy Metals sold off alongside other battery-metal stocks, the current A$16.99 share price sits against a 30 day share price return of 13.27% and a very large 1 year total shareholder...

With inflation trends mixed across regions, interest rates in focus and labour markets still holding up, many investors are looking for stocks that can grow earnings even as conditions shift. That is where the Healthy high growth potential screener comes in. It filters for companies that analysts expect to grow earnings strongly over the next 3 years while also passing basic financial health checks. In this article, you will see 3 stocks from this screener, along with a clear, plain-English...

Boss Energy (ASX:BOE) is back in focus after restarting uranium production at its Honeymoon project and receiving an analyst upgrade, drawing fresh attention to the stock despite ongoing ramp up and pricing challenges. See our latest analysis for Boss Energy. Boss Energy's A$1.19 share price has rebounded in the very short term, with a 1 day share price return of 3.03% and 7 day share price return of 12.26%. This sits against a 90 day share price return down 24.44% and a 1 year total...

Some of the losses seen by insiders who purchased AU$222.2k worth of Kuniko Limited ( ASX:KNI ) shares over the past...

Elliott Investment Management has put Northern Star Resources (ASX:NST) in focus after calling for substantial board changes and a comprehensive review of the business, following recent leadership changes at the gold producer. See our latest analysis for Northern Star Resources. Northern Star Resources shares closed at A$19.83 after a 1 day share price gain of 5.48%. The 30 day and year to date share price returns are still down, while the 5 year total shareholder return of 122.20% points to...

Polymetals Resources Ltd ( ASX:POL ) insiders who bought shares over the past year were rewarded handsomely last week...

Quite a few insiders have dramatically grown their holdings in Intelligent Monitoring Group Limited ( ASX:IMB ) over...

The recent earnings posted by Ricegrowers Limited ( ASX:SGLLV ) were solid, but the stock didn't move as much as we...

Insiders who bought AU$608.0k worth of EML Payments Limited ( ASX:EML ) stock in the last year recovered part of their...

Predictive Discovery Limited recently reported that PKF Perth resigned as its auditor with immediate effect, marking a governance change for the gold producer. This development comes as the company advances its West African production base and growth projects following its merger with Robex Resources. We’ll now examine how the immediate auditor resignation, alongside the Robex merger integration, could influence Predictive Discovery’s investment narrative. Find 9 companies with promising...

Westgold Resources Limited has completed the sale of its Peak Hill Gold Project to Great Boulder Resources for A$54.4 million, comprising A$25 million in cash, a 19.9% equity stake in Great Boulder, and a 1.0% NSR royalty over future gold production. This transaction materially reshapes Westgold’s asset base by swapping a non-core project for immediate liquidity and ongoing exposure to Peak Hill’s future output via equity and royalties. We’ll now examine how the Peak Hill divestment, which...

As the Australian stock market opens the new financial year on a flat note, hovering around 8,780 points amidst global uncertainties such as the U.S.-Iran tensions, investors are keenly observing dividend stocks for potential income opportunities. In this environment, selecting stocks with strong dividend yields can be an effective strategy for those seeking steady returns in a market where other indices show mixed performances.

As the Australian share market opens the new financial year flat, with futures hovering around 8,780 points, investors are keeping a close eye on global influences like the U.S.-Iran tensions and Wall Street's tech-driven momentum. In such a balanced yet uncertain environment, identifying undervalued stocks can be crucial for investors seeking to capitalize on potential discounts below intrinsic value.